High Field Bio
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
202 Building 2 Minsheng Pharmaceutical I...Website
www.highfieldbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About High Field Bio
HighField Biopharmaceuticals specializes in lipid-based therapeutics designed to navigate complex biological systems for the treatment of cancer, autoimmune, and metabolic diseases. Their innovative platforms, including ADCplex, TCEplex, and tLNPplex, focus on delivering high-quality lipid nanoparticles that efficiently target diseased tissues. The company aims to provide novel immuno-oncology solutions and has a pipeline featuring products like K16, K1, and HF50. HighField's advanced technologies leverage AI to enhance drug development and optimize treatment efficacy.Explore more
High Field Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is High Field Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on High Field Bio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at High Field Bio
Check out if High Field Bio is spiking on competitors!
Website visits: Recent activity has been detected on your website
High Field Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if High Field Bio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when High Field Bio launches new products
Click to see if High Field Bio had a recent Job posting/layoffs
Funding: Get notified immidiatlly once High Field Bio has new funding data
Recommended Actions
Reach out to Masked Content who joined High Field Bio as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
High Field Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
High Field Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about High Field Bio.
High Field Bio Tech Stack
A closer look at the technologies used by High Field Bio
See more technologies
High Field Bio News & Media
HighField Biopharmaceuticals Granted Clearance of IND in China for Clinical Trial of its Unique TRAFsomeTM T Cell Engager (HF50) To Treat Solid Tumor Cancers
HANGZHOU, China--(BUSINESS WIRE)--HighField Biopharmaceuticals Granted IND Clearance in China for Clinical Trial of Unique TRAFsome™ T Cell Engager (HF50) To Treat Solid Tumor CancersData from a Phase 1 Trial of HighField Biopharmaceuticals’ HF1K16 Show the New Immuno-Oncology Drug is Safe and Signals Efficacy in Treating Refractory Metastatic Cancers
HANGZHOU, China--(BUSINESS WIRE)--K16 targets myeloid-derived suppressor cells and an R/R glioma cohort suggests a survival benefit with several patients living for more than 2 yearsHighField Biopharmaceuticals’ mRNA-based HFG1 Demonstrates Potential as a Longer Acting GLP-1R Agonist for Diabetic Control and Weight Loss
HANGZHOU, China--(BUSINESS WIRE)--Diabetic monkeys experienced weight loss and HbA1c level reduction during an assessment period of two months following a single injection with HFG1.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding High Field Bio
Sign Up For FreeTo access detailed company insights
HighField Biopharmaceuticals specializes in lipid-based therapeutics designed to navigate complex biological systems for the treatment of cancer, autoimmune, and metabolic diseases. Their innovative platforms, including ADCplex, TCEplex, and tLNPplex, focus on delivering high-quality lipid nanoparticles that efficiently target diseased tissues. The... Read More
